EUVIMEDEUVIMED entdecken
Leitlinie

French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy

Raoul Belzeaux, Florence Gressier, Ludivine Boudieu, Adeline Arnould, Elsa Moreau, Julia Pastol, Eleni Tzavara, Anne Laure Sutter-Dallay, Ludovic Samalin

Archives of Women's Mental Health · 2024

DOI: 10.1007/s00737-024-01440-6 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Archives of Women's Mental Health, 2024. Verfasst von Raoul Belzeaux und 8 weiteren Autor:innen. Beteiligte Einrichtung: French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France. raoul.belzeaux@chu-montpellier.fr. Hauptthemen laut MEDLINE: Pregnancy Complications, Mood Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The French Society for Biological Psychiatry and Neuropsychopharmacology and the French-speaking Marcé Society have joined forces to establish expert recommendations on the prescription of psychotropic drugs before, during, and after pregnancy in women with major depressive disorder (MDD) and bipolar disorder (BD). METHODS: To elaborate recommendations, we used the RAND/UCLA Appropriateness Method, which combines scientific evidence and expert clinicians' opinions. A written survey was completed by 48 psychiatrists, who have expertise in the management of mood disorders and/or in perinatal psychiatry. Key recommendations are provided by the scientific committee based on data analysis and interpretation of the results of the survey. RESULTS: The recommendations address the following three areas that are deemed essential in women with mood disorders, with an emphasis on screening, treatment options, and monitoring: (i) management of mood disorders in women of childbearing age, (ii) management during pregnancy, (iii) management during the post-partum period. As first-line strategies, experts recommend treating mood symptoms during pregnancy and maintaining a pharmacological treatment, even in euthymic or stabilized patients. First-line options include only medications with no teratogenic risk, and during breastfeeding, only medications without evidence of adverse effects in nursing infants. CONCLUSION: The expert consensus guidelines will help facilitate treatment decisions for clinicians in the daily assessment and management of mood disorders in women of childbearing age, during pregnancy, and in the post-partum period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy ComplicationsMood DisordersHumansFemalePregnancyFrancePsychotropic DrugsBipolar DisorderMajor Depressive DisorderAdultSocieties, MedicalBiological PsychiatryPsychopharmacology

Stichwörter der Autor:innen

Bipolar disorderChildbearing ageMajor depressive disorderMood disordersPost-partum pharmacotherapyPregnancy

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France. raoul.belzeaux@chu-montpellier.fr.
  • Pôle Universitaire de Psychiatrie, CHU de Montpellier, 39 Avenue C. Flahaut, 34090, Montpellier, France. raoul.belzeaux@chu-montpellier.fr.
  • Société Marcé Francophone, Chatenay Malabry, France.
  • Service Hospitalo-Universitaire de Psychiatrie, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Université Paris-Saclay, Equipe Moods, INSERM, UMR-1018, CESP, Le Kremlin…
  • Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, (UMR 6602), Clermont-Ferrand, France.
  • French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France.

Zitieren

APA

Belzeaux, R., Gressier, F., Boudieu, L., Arnould, A., Moreau, E., Pastol, J., Tzavara, E., Sutter-Dallay, A. L., & Samalin, L. (2024). French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy. Archives of Women's Mental Health. https://doi.org/10.1007/s00737-024-01440-6

Vancouver

Belzeaux R, Gressier F, Boudieu L, Arnould A, Moreau E, Pastol J, et al. French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy. Archives of Women's Mental Health. 2024. doi:10.1007/s00737-024-01440-6

BibTeX
@article{Belzeaux2024,
  author = {Belzeaux, Raoul and Gressier, Florence and Boudieu, Ludivine and Arnould, Adeline and Moreau, Elsa and Pastol, Julia and Tzavara, Eleni and Sutter-Dallay, Anne Laure and Samalin, Ludovic},
  title = {French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy},
  journal = {Archives of Women's Mental Health},
  year = {2024},
  doi = {10.1007/s00737-024-01440-6}
}
Kostenlos starten →